Company News
Friday preview: US producer prices, UK retail sales in focus
Investors' focus at the end of the week will shift back towards the inflation picture in the U. S.
Director dealings: Greencore non-executive director makes share purchase
Greencore revealed on Thursday that non-executive director Linda Hickey had acquired 50,000 ordinary shares in the London-listed food company.
Biome Technologies secures £490,000 contract
Biome Technologies said on Thursday that its RF Technologies division has secured a contract with a revenue value of £490,000 to supply a second novel induction furnace system (‘The System’) to a global manufacturer of scientific glass products.
Centrica posts fall in annual profit on lower energy prices
British Gas owner Centrica posted a fall in annual profits on the back of “sharply lower” commodity prices.
Tekcapital investee Guident inks partnership with AuVe Tech
Tekcapital announced on Thursday that its autonomous vehicle technology investee Guident had inked a strategic partnership with AuVe Tech, an Estonian company specialising in autonomous transportation systems.
Gattaca flags fall in first-half net fee income
Specialist staffing company Gattaca said in a trading update on Thursday that it expected net fee income to have fallen to £18. 9m in the first half, making for a 16% year-on-year decrease from £22. 5m.
White Stuff founders exploring a sale - report
The founders of fashion retailer White Stuff are reportedly exploring a potential sale.
Bank of Georgia in talks over potential acquisition of Ameriabank
Bank of Georgia confirmed on Thursday that it is in advanced talks with Ameriabank about a potential acquisition of the Armenian bank.
Checkit ends financial year in line with expectations
Mobile worker software specialist Checkit reported a 16% increase in annual recurring revenue in a trading update on Thursday, to £13. 3m for the financial year just ended, meeting expectations.
Sareum reports positive progress in psoriasis programme
Sareum announced significant milestones in its phase 1a clinical trial for SDC-1801, its lead programme aimed at addressing autoimmune diseases such as psoriasis, on Thursday.
Quadrise inks project development deal with new and existing partners
Quadrise announced the signing of a project development agreement (PDA) with renewable biofuels specialist BTG Bioliquids and Euthenia Energy Group on Thursday.
Swisscom sole bidder for Vodafone's Italian assets - report
Swisscom has become the sole party still in discussions with Vodafone Group about its Italian assets, it was reported on Thursday.
Commerzbank posts strongest performance in 15 years
German banking giant Commerzbank reported its strongest financial performance in 15 years on Thursday, buoyed by a significant increase in net profit driven by high interest rates.
Landore upbeat on outcome of Junior Lake soil sampling
Landore Resources announced the outcomes of its 2023 soil sampling initiative on Thursday, carried out adjacent to its flagship BAM Gold Project on the Junior Lake Property in Ontario, Canada.
Jet2 'encouraged' by early bookings, slightly raises profit guidance
Leisure travel group Jet2 said on Thursday that it was "encouraged" by early bookings for Summer 2024, leading it to "tighten and slightly raise" full-year profit guidance.
Ariana Resources reports progress at Zimbabwe's Dokwe project
Mineral explorer and developer Ariana Resources updated the market on the ongoing due diligence programme concerning the Dokwe Gold Project in Zimbabwe on Thursday, owned by Rockover Holdings.
Interim profits slide at MJ Gleeson
MJ Gleeson posted a slide in half-year profits on Thursday, but flagged "encouraging" signs of improving demand for the rest of the year.
Renault shares surge on dividend boost
Shares in Renault made strong gains on Thursday after the French carmaker rewarded investors with a large dividend hike.
N4 Pharma shares jump on latest Nuvec developments
N4 Pharma announced a significant advancement in the development of Nuvec, an innovative delivery system tailored for cancer treatments, gene therapy, and vaccines, on Thursday.
Barclays eyes SocGen's UK private bank - report
Barclays is considering bidding for Societe Generale’s UK private bank, it was reported on Thursday.